The Regulatory Review
Article: Off-Label Drug Use Liability Julia Englebert
Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use.
1,101 posts by 291 firms and lawyers
Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.
Scholar argues that FDA approval should not save drug makers from state-law claims arising from off-label use.